Tenaya Therapeutics, Inc. Capital Expenditures Incurred but Not yet Paid
Tenaya Therapeutics, Inc. (TNYA) reported Capital Expenditures Incurred but Not yet Paid of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-05
- Tenaya Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was -$100.00K.
- Tenaya Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $100.00K, a 27.54% decline year-over-year.
- Tenaya Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $60.00K, a 150.00% increase year-over-year.
- Tenaya Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was -$7.00K, a 102.97% decline year-over-year.
- Tenaya Therapeutics, Inc. capital expenditures incurred but not yet paid for fiscal 2025 was $60.00K, a 83.24% decline from fiscal 2024.
- Tenaya Therapeutics, Inc. capital expenditures incurred but not yet paid for fiscal 2024 was $358.00K, a 43.78% increase from fiscal 2023.
- Tenaya Therapeutics, Inc. capital expenditures incurred but not yet paid for fiscal 2023 was $249.00K, a 54.64% decline from fiscal 2022.
- Tenaya Therapeutics, Inc. capital expenditures incurred but not yet paid for fiscal 2022 was $549.00K, a 86.61% decline from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $0.00 10-Q · filed 2026-08-05 | $60.00K derived: sum of 3 quarters · filed 2026-08-05 | $53.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $100.00K 10-Q · filed 2026-05-06 | $160.00K derived: sum of 2 quarters · filed 2026-05-06 | $153.00K derived: sum of 3 quarters · filed 2026-05-06 | $22.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $53.00K derived: sum of 2 quarters · filed 2026-03-11 | -$78.00K derived: sum of 3 quarters · filed 2026-08-05 | $60.00K 10-K · filed 2026-03-11 |
| 2025-09-30 | -$7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$138.00K derived: sum of 2 quarters · filed 2026-08-05 | $0.00 10-Q · filed 2025-11-10 | $24.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$131.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $7.00K 10-Q · filed 2026-08-05 | $31.00K derived: sum of 3 quarters · filed 2026-08-05 | $267.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $138.00K 10-Q · filed 2026-05-06 | $162.00K derived: sum of 2 quarters · filed 2026-05-06 | $398.00K derived: sum of 3 quarters · filed 2026-05-06 | $489.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $260.00K derived: sum of 2 quarters · filed 2026-03-11 | $351.00K derived: sum of 3 quarters · filed 2026-03-11 | $358.00K 10-K · filed 2026-03-11 |
| 2024-09-30 | $236.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $327.00K derived: sum of 2 quarters · filed 2025-11-10 | $334.00K 10-Q · filed 2025-11-10 | $274.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $91.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $98.00K 10-Q · filed 2025-08-06 | $38.00K derived: sum of 3 quarters · filed 2025-08-06 | $303.00K derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $7.00K 10-Q · filed 2025-05-07 | -$53.00K derived: sum of 2 quarters · filed 2025-05-07 | $212.00K derived: sum of 3 quarters · filed 2025-05-07 | -$114.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | -$60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $205.00K derived: sum of 2 quarters · filed 2025-03-10 | -$121.00K derived: sum of 3 quarters · filed 2025-03-10 | $249.00K 10-K · filed 2025-03-10 |
| 2023-09-30 | $265.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$61.00K derived: sum of 2 quarters · filed 2024-11-06 | $309.00K 10-Q · filed 2024-11-06 | $595.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | -$326.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $44.00K 10-Q · filed 2024-08-08 | $330.00K derived: sum of 3 quarters · filed 2024-08-08 | -$2.47M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $370.00K 10-Q · filed 2024-05-14 | $656.00K derived: sum of 2 quarters · filed 2024-05-14 | -$2.14M derived: sum of 3 quarters · filed 2024-05-14 | -$4.36M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $286.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | -$2.51M derived: sum of 2 quarters · filed 2024-03-18 | -$4.73M derived: sum of 3 quarters · filed 2024-03-18 | $549.00K 10-K · filed 2024-03-18 |
| 2022-09-30 | -$2.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$5.02M derived: sum of 2 quarters · filed 2023-11-08 | $263.00K 10-Q · filed 2023-11-08 | $686.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | -$2.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $3.06M 10-Q · filed 2023-08-09 | $3.48M derived: sum of 3 quarters · filed 2023-08-09 | $5.21M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $5.28M 10-Q · filed 2023-05-10 | $5.71M derived: sum of 2 quarters · filed 2023-05-10 | $7.43M derived: sum of 3 quarters · filed 2023-05-10 | $8.93M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $423.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $2.15M derived: sum of 2 quarters · filed 2023-03-08 | $3.65M derived: sum of 3 quarters · filed 2023-03-08 | $4.10M 10-K · filed 2023-03-08 |
| 2021-09-30 | $1.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $3.23M derived: sum of 2 quarters · filed 2022-11-10 | $3.68M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $1.95M 10-Q · filed 2022-08-10 | ||
| 2021-03-31 | $452.00K 10-Q · filed 2022-05-11 | |||
| 2020-12-31 | $364.00K 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |